Laboratory of Pharmacology, Department of Internal Medicine, and Center of Excellence for Biomedical Research (CEBR), University of Genova, 16132, Genoa, Italy.
Department of Physics, University of Genova, Genoa, Italy.
Neurotox Res. 2017 Oct;32(3):381-397. doi: 10.1007/s12640-017-9749-2. Epub 2017 May 25.
Glia over-stimulation associates with amyloid deposition contributing to the progression of central nervous system neurodegenerative disorders. Here we analyze the molecular mechanisms mediating microglia-dependent neurotoxicity induced by prion protein (PrP)90-231, an amyloidogenic polypeptide corresponding to the protease-resistant portion of the pathological prion protein scrapie (PrP). PrP90-231 neurotoxicity is enhanced by the presence of microglia within neuronal culture, and associated to a rapid neuronal [Ca] increase. Indeed, while in "pure" cerebellar granule neuron cultures, PrP90-231 causes a delayed intracellular Ca entry mediated by the activation of NMDA receptors; when neuron and glia are co-cultured, a transient increase of [Ca] occurs within seconds after treatment in both granule neurons and glial cells, then followed by a delayed and sustained [Ca] raise, associated with the induction of the expression of inducible nitric oxide synthase and phagocytic NADPH oxidase. [Ca] fast increase in neurons is dependent on the activation of multiple pathways since it is not only inhibited by the blockade of voltage-gated channel activity and NMDA receptors but also prevented by the inhibition of nitric oxide and PGE release from glial cells. Thus, Ca homeostasis alteration, directly induced by PrP90-231 in cerebellar granule cells, requires the activation of NMDA receptors, but is greatly enhanced by soluble molecules released by activated glia. In glia-enriched cerebellar granule cultures, the activation of inducible nitric oxide (iNOS) and NADPH oxidase represents the main mechanism of toxicity since their pharmacological inhibition prevented PrP90-231 neurotoxicity, whereas NMDA blockade by D(-)-2-amino-5-phosphonopentanoic acid is ineffective; conversely, in pure cerebellar granule cultures, NMDA blockade but not iNOS inhibition strongly reduced PrP90-231 neurotoxicity. These data indicate that amyloidogenic peptides induce neurotoxic signals via both direct neuron interaction and glia activation through different mechanisms responsible of calcium homeostasis disruption in neurons and potentiating each other: the activation of excitotoxic pathways via NMDA receptors and the release of radical species that establish an oxidative milieu.
胶质细胞过度兴奋与淀粉样沉积有关,有助于中枢神经系统神经退行性疾病的进展。在这里,我们分析了介导朊病毒蛋白(PrP)90-231 诱导的小胶质细胞依赖性神经毒性的分子机制,PrP90-231 是一种对应于病理性朊病毒瘙痒(PrP)的蛋白酶抗性部分的淀粉样多肽。在神经元培养物中小胶质细胞的存在增强了 PrP90-231 的神经毒性,并与神经元内快速 Ca 增加有关。事实上,虽然在“纯”小脑颗粒神经元培养物中,PrP90-231 通过激活 NMDA 受体引起延迟的细胞内 Ca 内流;但当神经元和神经胶质细胞共培养时,在处理后几秒钟内,颗粒神经元和神经胶质细胞中都会发生短暂的 [Ca] 增加,随后是延迟和持续的 [Ca] 升高,与诱导诱导型一氧化氮合酶和吞噬 NADPH 氧化酶的表达相关。神经元中的 [Ca] 快速增加依赖于多条途径的激活,因为它不仅被电压门控通道活性和 NMDA 受体的阻断所抑制,而且还被神经胶质细胞中一氧化氮和 PGE 释放的抑制所阻止。因此,由 PrP90-231 直接诱导的小脑颗粒细胞中 Ca 动态平衡的改变需要 NMDA 受体的激活,但可被激活的神经胶质细胞释放的可溶性分子大大增强。在富含神经胶质细胞的小脑颗粒培养物中,诱导型一氧化氮合酶(iNOS)和 NADPH 氧化酶的激活是毒性的主要机制,因为它们的药理学抑制阻止了 PrP90-231 的神经毒性,而 D(-)-2-氨基-5-磷戊酸对 NMDA 的阻断无效;相反,在纯小脑颗粒培养物中,NMDA 阻断而不是 iNOS 抑制强烈降低了 PrP90-231 的神经毒性。这些数据表明,淀粉样肽通过直接神经元相互作用和通过负责神经元钙稳态破坏和相互增强的不同机制激活神经胶质细胞来诱导神经毒性信号:通过 NMDA 受体激活兴奋性毒性途径和释放自由基物质建立氧化环境。